An experienced CBSE Class 10 Mathematics teacher reveals proven strategies, practical tips, and smart problem-solving ...

Utilizing its innovative ADC payload platform, Akari is advancing a new class of immuno-oncology ADCs built on the platform ...

Two dividend stocks with proven track records are flashing buy signals right now. These two industry leaders make dividend ...

Two human leukocyte antigen (HLA) class I alleles are independently associated with an increased risk for allopurinol-induced severe cutaneous adverse reactions (SCARs), according to a study published ...

State boards should go after the attorneys who are enabling the administration's disregard for the rule of law.

When Ryan Brazil told her students, “We make space for each other,” she offered a truth that extends well beyond her ...

On Tuesday night, Zohran Mamdani — a longtime member of the Democratic Socialists of America (DSA) — won the mayoralty of ...

Akari Therapeutics (AKTX) announced its abstract highlighting immune mechanism-of-action data for its novel ADC payload, PH1. The abstract is now ...

Ritwik Ghatak’s centenary revives the debate on “difficult cinema” and its power to shape imagination, politics, and the ...

Fourth Air Canada Café location expands airline’s growing network of grab-and-go lounges Design inspired by aviation and Vancouver’s natural ...

MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing ...